169 related articles for article (PubMed ID: 24088121)
1. Making data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative.
Samwald M; Freimuth RR
Pharmacogenomics; 2013 Oct; 14(13):1529-31. PubMed ID: 24088121
[No Abstract] [Full Text] [Related]
2. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
Stud Health Technol Inform; 2014; 205():261-5. PubMed ID: 25160186
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: the path to individualised patient care.
Adelung MR; Fitzsimons VM
Br J Nurs; 2014 Jul 10-23; 23(13):738-9. PubMed ID: 25072336
[No Abstract] [Full Text] [Related]
4. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
Stud Health Technol Inform; 2014; 198():25-31. PubMed ID: 24825681
[TBL] [Abstract][Full Text] [Related]
5. Using pharmacogenetics to prevent severe adverse reactions to capecitabine.
García-González X; López-Fernández LA
Pharmacogenomics; 2017 Aug; 18(13):1199-1213. PubMed ID: 28746000
[No Abstract] [Full Text] [Related]
6. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
[TBL] [Abstract][Full Text] [Related]
7. Are we PREPAREd? Concerning the "PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study".
De Carmo Campos A; Cardoso ML; Vicente A
Acta Med Port; 2023 Oct; 36(10):689-690. PubMed ID: 37788651
[No Abstract] [Full Text] [Related]
8. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
9. Databases in the area of pharmacogenetics.
Sim SC; Altman RB; Ingelman-Sundberg M
Hum Mutat; 2011 May; 32(5):526-31. PubMed ID: 21309040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics arrives.
Petsko GA
Genome Biol; 2004; 5(6):108. PubMed ID: 15186481
[TBL] [Abstract][Full Text] [Related]
11. Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
Tan-Koi WC; Sung C; Chong YY; Lateef A; Pang SM; Vasudevan A; Aw D; Lui NL; Lee SX; Ren EC; Koay ES; Tay YK; Lim YL; Lee HY; Dong D; Loke C; Tan L; Limenta M; Lee EJ; Toh D; Chan CL
Pharmacogenomics; 2017 Jun; 18(9):881-890. PubMed ID: 28594314
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
Jud Schefer R; Paine Kuhn C; Demuth D
Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
[TBL] [Abstract][Full Text] [Related]
13. Herbal Remedies: Throwing Off Phenotype Prediction-A Culprit for Pharmacogenomic-Guided Drug Therapy and Drug Safety.
Dandara C; Thomford NE; Bapiro TE
Clin Pharmacol Ther; 2019 Aug; 106(2):302-304. PubMed ID: 31245840
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics: The right drug for you.
Drew L
Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
[No Abstract] [Full Text] [Related]
15. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
Lanvers-Kaminsky C; Zehnhoff-Dinnesen AA; Parfitt R; Ciarimboli G
Clin Pharmacol Ther; 2017 Apr; 101(4):491-500. PubMed ID: 28002638
[TBL] [Abstract][Full Text] [Related]
16. Clinical association between pharmacogenomics and adverse drug reactions.
Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
[TBL] [Abstract][Full Text] [Related]
17. Progress and Challenges in Pharmacogenomics.
Van Driest SL; Cascorbi I
Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
[No Abstract] [Full Text] [Related]
18. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE
Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517
[No Abstract] [Full Text] [Related]
19. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
20. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.
Cavallari LH; Beitelshees AL; Blake KV; Dressler LG; Duarte JD; Elsey A; Eichmeyer JN; Empey PE; Franciosi JP; Hicks JK; Holmes AM; Jeng L; Lee CR; Lima JJ; Limdi NA; Modlin J; Obeng AO; Petry N; Pratt VM; Skaar TC; Tuteja S; Voora D; Wagner M; Weitzel KW; Wilke RA; Peterson JF; Johnson JA
Clin Transl Sci; 2017 May; 10(3):143-146. PubMed ID: 28294551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
